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Aims Previous studies have reported the safety and feasibility of both time-domain optical coherence tomography (TD-
OCT) and Fourier-domain OCT (FD-OCT) in highly selected patients and clinical settings. However, the generalizabil-
ity of these data is limited, and data in unselected patient populations reflecting a routine cathlab practice are lacking.
We compared safety of intracoronary FD-OCT imaging to intravascular ultrasound (IVUS) imaging in a large real-world
series of consecutive patients who underwent invasive imaging during coronary catheterization in our centre.
Methods
and results
This is a prospective, single-centre registry of patients scheduled for coronary angiography or intervention undergoing
intracoronary imaging with FD-OCT or IVUS between April 2008 and December 2013. Intra-procedural and major in-
hospital adverse events that could be possibly related to invasive imaging were registered routinely by the operator as
part of our clinical report and prospectively recorded in our database. These events were retrospectively individually
adjudicated by an independent safety committee. Between April 2008 and December 2013, 13 418 diagnostic or inter-
ventional coronary catheterization procedures were performed. Of these, 1142 procedures used OCT and 2476 pro-
cedures used IVUS. Invasive imaging-related complications were rare, did not differ between the two imaging methods
(OCT: n ¼ 7, 0.6%; IVUS: n ¼ 12, 0.5%; P ¼ 0.6), and were self-limiting after retrieval of the imaging catheter or easily
treatable in the catheterization laboratory. No major adverse events, prolongation of hospital stay, or permanent
patient harm was observed.
Conclusion FD-OCT is safe in an unselected and heterogeneous group of patients with varying clinical settings.
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Introduction
Intracoronary optical coherence tomography (OCT) is increasingly
used in the catheterization laboratory. Various clinical applications
have been proposed, including assessment of plaque morphology
in angiographic ambiguous lesions, guidance of stent placement dur-
ing percutaneous coronary interventions (PCI), and follow-up stent
assessment.1,2 In the early days of the first generation, time-
domain OCT (TD-OCT), intracoronary application was hampered
by the need for proximal balloon occlusion to limit antegrade blood
flow in combination with distal delivery of a translucent flush solu-
tion in order to create a blood-free environment during OCT data
acquisition.3 The currently commercially available and widespread
used second-generation intracoronary Fourier-domain OCT
(FD-OCT) was developed to overcome these limitations, allowing
for a simplification of the image acquisition procedure. Importantly,
the imaging device was redesigned to a monorail OCT imaging cath-
eter that could be introduced into the coronary artery over any PCI
* Corresponding author. Tel: +31 10 70 35729; Fax: +31 10 70 32357. Email: e.regar@erasmusmc.nl
Published on behalf of the European Society of Cardiology. All rights reserved. & The Author 2016. For permissions please email: journals.permissions@oup.com.
doi:10.1093/ehjci/jew037
European Heart Journal – Cardiovascular Imaging (2017) 18, 467–474
online publish-ahead-of-print 18 March 2016
guide wire of choice, which substantially facilitated instrumentation.
Further, the data acquisition speed was increased by using frequency
domain techniques that are capable of acquiring images at high
speed (up to 180 frames/s) and with fast pullback (up to 40 mm/s),
alleviating the need for proximal balloon occlusion during imaging
and the risk of creating ischaemia during imaging.4 Previous smaller
studies5–10 have reported the safety and feasibility of both TD-OCT
and FD-OCT in highly selected patients and clinical settings.
However, the generalizability of these data is limited, and data in
unselected patient populations reflecting a routine cathlab practice
are lacking.
We report safety of intracoronary FD-OCT imaging in a large
real-world series of consecutive patients who underwent OCT dur-
ing coronary catheterization in our centre since the introduction of
FD-OCT imaging in 2008 and compare the results with our intravas-
cular ultrasound (IVUS) safety data from the same time period.
Methods
Study population
This is a single-centre study, prospectively evaluating the safety of
FD-OCT. Consecutive patients who underwent FD-OCT examination
during cardiac catheterization between April 2008 and December 2013
were included. These data were then compared with the cohort of pa-
tients who underwent IVUS within the same time period. All consecu-
tive patients who underwent intracoronary OCT or IVUS during the
study period were included. Additionally, to assess generalizability of
our data, the indications for catheterization and patient baseline charac-
teristics were also compared with the cohort that, at the discretion of
the operators, did not undergo any form of invasive imaging during the
same time period. Both OCT and IVUS were performed either as part of
various clinical trial protocols or at the discretion of the operators. In
the latter case, the exclusion criteria were acute, life-threatening
haemodynamic instability and coronary anatomy not deemed suitable
for introduction of an imaging catheter, such as extensive tortuosity
or calcification or a lumen diameter .5 mm, beyond the penetration
depth of OCT and lesions considered too tight to allow crossing of a
device of 3F. In acute settings, restoration of antegrade flow always
was the main priority and had to be secured before introduction of
an imaging catheter.
Invasive imaging procedure
Invasive imaging was performed via radial or femoral access according to
routine clinical standard in our centre using 6F (range 5–7F) guide ca-
theters. Patients received weight-adjusted intravenous heparin in order
to maintain the activated clotting time of .300 s and intracoronary
administration of 0.2 mg nitroglycerine, as standard prior to invasive
imaging. Imaging catheters were advanced distally to a region of interest
over 0.014-inch conventional angioplasty guide wires, chosen at the
discretion of the operators. All the imaging systems have dedicated
pullback devices and consoles that allow data processing and storage.
IVUS image acquisition
IVUS images were acquired with different systems (Galaxy I, Galaxy II
and iLab: Boston Scientific, Marlborough, MA, USA; In-Vision Gold
and S5 imaging system: Volcano Corporation, San Diego, CA, USA).
Different types of catheters (range 20–45 MHz, 3.2–3.5F) were used
with a default motorized pullback speed of 0.5 mm/s.
OCT image acquisition
OCT imaging was performed with commercially available FD-OCT sys-
tems (Lightlab C7XR, Ilumien and Ilumien Optis: St Jude Medical, St Paul,
MN, USA; Terumo Lunawave: Terumo, Tokyo, Japan) and in a limited
number of patients with several different OCT prototypes (Lightlab
M4: St Jude Medical, St Paul, MN, USA; MGH OCT system: The
Wellman Center for Photomedicine, Boston, MA, USA; Volcano
OCT system: Volcano Corporation, San Diego, CA, USA).
OCT imaging probes had a short monorail design with a fibre-optic
imaging core integrated into a catheter. The catheter profile ranged
from 2.4 to 2.7F. During OCT image acquisition, the optic imaging
core rotated at a rate of 100–180 revolutions/s. OCT pullbacks were
performed automated at the pullback speed of generally 20 mm/s (range
10–40 mm/s) during simultaneous flushing of viscous iso-osmolar con-
trast (Iodixanol 320, VisipaqueTM, GE Health Care, Cork, Ireland at
378C) through the guiding catheter by use of an automated power in-
jector (Medrad Inc., Warrendale, PA, USA) with a flow rate of 3 mL/s
as standard setting, or in selected cases by manual injection.
Safety assessment
Both major in-hospital and intra-procedural adverse events were
recorded and considered as potential imaging-related complications.
Major in-hospital adverse events were defined as cerebrovascular event,
emergency revascularization, and death. Intra-procedural events were
defined as the occurrence of clinical symptoms (new or worsened chest
pain or shortness of breath), adverse angiographic outcomes (dissec-
tion, perforation, vasospasm, thrombus formation, and no-reflow), or
electrocardiographic changes (ST-segment elevation, severe bradycar-
dia, and ventricular arrhythmias) requiring interruption of the imaging
procedure during intracoronary imaging and were routinely registered
by the operator as a standard item being part of our clinical PCI report
and collected in our PCI database. In addition, all free text comments in
the PCI database/reporting system were screened for ‘OCT’ or ‘IVUS’.
Comments containing these keywords were individually reviewed for
any possible association with an adverse event. Major peri-procedural
adverse events were also recorded and defined as cerebrovascular
event, emergency revascularization, and death.
Adjudication
Complications were individually adjudicated by an independent safety
committee by thorough review of the patient files, procedural notes,
angiogram, and intracoronary images. A complication was considered
related to the imaging procedure if it would not have occurred if the in-
vasive imaging would not have been performed. ‘Definitely related’ was
used for complications that were with great certainty caused by the in-
vasive imaging. If the relation between invasive imaging procedure and
registered event was less clear, but could not be completely ruled
out, the event was defined as ‘possibly related’. Possible and definite in-
vasive imaging-related events were categorized as self-limiting after
withdrawal of the imaging catheter, requiring action or major adverse
events. The safety committee consisted of two teams that reviewed
the events independently. In case of disagreement, the case was re-
evaluated and discussed between both teams until consensus was
reached. Each team consisted of a senior invasive cardiologist not direct-
ly involved in clinical or research coronary imaging projects and an
invasive imaging expert (R.J.G. and J.M.R.L.; M.V. and K.T.W.).
Statistical analysis
Continuous data were expressed as mean values+ SD. An
independent-samples t-test was used to analyse continuous data be-
tween two groups and ANOVA for more than two groups. Significance
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of associations of categorical variables were assessed using the x2 test
or Fisher’s exact test, as appropriate. Univariate analyses to identify pre-
dictors of an adverse event during image acquisition were performed
using a logistic regression model. A P-value of ,0.05 was considered
significant.
Results
Patient population
Between April 2008 and December 2013, 13 418 diagnostic or inter-
ventional coronary catheterization procedures were performed in
our centre. During 1142 procedures (984 patients with 3045
pullbacks) FD-OCT was used, and during 2476 procedures (2054
patients with 5148 pullbacks) IVUS was used. A combination of
OCT and IVUS images were acquired during 307 procedures. Inva-
sive imaging was performed by 13 different senior operators, of
whom 11 had .5 years of experience and the other two between
1 and 5 years of experience as senior operator in a catheterization
laboratory. Baseline demographic characteristics of all patients
who underwent OCT or IVUS are displayed in Table 1. Invasive im-
aging was used in a variety of clinical settings. Patients undergoing
OCT had less renal failure (5.3 vs. 9.1%, P, 0.001) when compared
with IVUS. OCT imaging was performed more often in patients with
ST-elevation myocardial infarction (24.7 vs. 14.5, P, 0.001). Proced-
ural characteristics are given in Table 2. The mean number of pull-
backs per procedure was significantly higher in the OCT group
compared with IVUS (2.66 vs. 2.07, P, 0.001), which might be ex-
plained in part by the shorter artery segment, which can be visualized
in one pullback (typically 50 mm OCT vs. 100 mm IVUS). Imaged
vessels and lesion types were roughly equal. Clearing of the coronary
from blood during OCT imaging was performed with a contrast flush
rate of 3 mL/s in 78% and 4 mL/s in 21% of the pullbacks.
Generalizability of invasive imaging
cohorts
Table 3 shows the comparison of baseline characteristics of the
OCT and IVUS cohorts to the population that did not undergo in-
vasive imaging within the same time window. The most pronounced
differences were the higher incidence of renal failure (12.7 vs. 5.3 vs.
9.1%, P, 0.001) in the non-imaging group, the lower incidence of
patients with a prior PCI (26.9 vs. 46.4 vs. 42.7%), and the larger
number of type C lesions (35.9 vs. 25.2 vs. 24.1%, P, 0.001)
when compared with OCT and IVUS, respectively. Figure 1 illus-
trates three examples of clinical settings that are typically consid-
ered difficult for invasive imaging acquisition. OCT images were
successfully acquired in all of these cases without complications.
Safety assessment
After adjudication, 7 (0.6%) complications that occurred during im-
age acquisition were possibly or definitely related to OCT and 12
(0.5%) to IVUS imaging (P ¼ 0.6) (Figure 2). Table 4 further specifies
the complications as adjudicated. Transient ST-elevation requiring
withdrawal of the imaging catheter was seen in 0.26 vs. 0.08%
(P ¼ 0.2), hypotension during image acquisition in 0.18 vs. 0.04%
(P ¼ 0.2), coronary spasm requiring infusion of additional intracor-
onary nitroglycerin in 0.09 vs. 0.04% (P ¼ 0.6), thrombus formation
in 0.09 vs. 0.16% (P ¼ 0.6), dissection of the imaged vessel in 0.00 vs.
0.12% (P ¼ 0.2), and stent deformation in 0.00 vs. 0.04% (P ¼ 0.5)
during OCT and IVUS imaging, respectively. The event rate per
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Table 1 Characteristics of all consecutive patients
undergoing invasive imaging in our centre between 2008
and 2013
Procedures OCTa IVUSa P-value
n 1142 2476
Age, years 61.9+11.1 62.6+11.2 0.112
Male 853 (74.7) 1852 (74.8) 0.967
Risk factors
Hypertension 589 (53.9) 1465 (62.0) ,0.001
Diabetes 206 (18.1) 500 (20.5) 0.105
Dyslipidaemia 600 (55.3) 1413 (60.4) 0.006
Current smokers 299 (26.3) 576 (23.5) 0.073
Family history 471 (44.0) 1025 (44.2) 0.911
History
Prior myocardial infarction 344 (30.1) 776 (31.3) 0.462
Prior CABG 50 (4.4) 136 (5.5) 0.169
Prior PCI 529 (46.3) 1058 (42.7) 0.047
Renal Failure 60 (5.3) 224 (9.1) ,0.001
Indications for
catheterization
,0.001
Stable angina 433 (37.9) 1114 (45.0) ,0.001
Unstable angina 180 (15.7) 466 (18.8) 0.028
Non-STEMI 97 (8.5) 233 (9.4) 0.385
STEMI 282 (24.7) 360 (14.5) ,0.001
Other 150 (13.1) 303 (12.2) 0.45
aA combination of OCT and IVUS images were acquired during 307 procedures.
Age: mean+ standard deviation; other values: n (%).
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Table 2 Invasive imaging procedure details
Procedures OCT IVUS P-value
n 1142 2476
Mean number of pullbacks 2.66+1.54 2.07+1.32 ,0.001
Mean number of imaged
vessels
1.18+0.42 1.28+0.51 ,0.001
Total pullbacks, n 3042 5135
Pullback distribution among
vessels
,0.001
LAD 1484 (48.8) 2459 (47.9) 0.436
LCX 577 (19.0) 1136 (22.1) 0.001
RCA 846 (27.8) 1266 (24.7) 0.002
Other 135 (4.4) 274 (5.3) 0.074
Lesion type, n 946 1927 0.584
A 115 (12.2) 214 (11.1) 0.418
B1 235 (24.8) 519 (26.9) 0.241
B2 358 (37.8) 729 (37.8) 1.000
C 238 (25.2) 465 (24.1) 0.549
Values in n (%) or mean (+standard deviation).
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pullback was the same for both modalities (0.23%). Figure 3 shows an
example of a typical angiographic and OCT image of coronary
spasm occurring during image acquisition. A more detailed descrip-
tion of all the complications that were encountered can be found in
the Supplementary data online.
Risk factors for adverse event
All baseline characteristics and indications for catheterization were
tested in univariate analyses for the risk of invasive imaging events
(see Supplementary data online, Table S1). The use of both modal-
ities, the total number of pullbacks, and the total number of inva-
sively imaged main vessels were also tested. No predictor of
adverse events was identified in the individual OCT and IVUS co-
horts, nor in the combined invasive imaging cohort. Additionally,
the impact of the interventional cardiologist’s experience with
the use of invasive imaging on the risk of an adverse events was
evaluated. When compared with the most experienced operator,
there was no significant increase in risk for every individual senior
operator.
Discussion
The present study demonstrates that intracoronary OCT and IVUS
imaging is comparably safe in an unselected and heterogeneous
group of patients with varying clinical settings, reflecting daily
routine catheterization laboratory practice in a tertiary care cen-
tre. Imaging-related events were scarce, with a similar incidence
for OCT and IVUS imaging and most importantly, self-limiting
after withdrawal of the imaging catheter or easily treatable in
the catheterization laboratory. No major adverse events, pro-
longation of hospital stay, or permanent patient harm was
observed.
Comparison between the OCT and IVUS
cohorts
During the study period, the frequency in the use of OCT and IVUS
has changed in our centre. In 2008, OCT was not yet CE marked
and, thus, infrequently used. In 2013, however, the use of OCT
and IVUS has balanced out (Figure 4). While IVUS was more often
performed in patients with stable angina, OCT was used more often
in ST-segment elevation myocardial infarction (STEMI) patients.
OCT has a higher sensitivity in visualizing thrombus and plaque
ruptures, often present in STEMI patients.
OCT and IVUS were used in a heterogeneous population and
in several clinical settings. Although most non-imaging variables in
Table 3 differ significantly from the OCT and IVUS cohorts, most dif-
ferences can be explained by the features that are inextricably linked
to both modalities. For example, in patients with renal failure, X-ray
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Table 3 Comparison between invasive imaging cohorts and non-imaging population
OCT IVUS Non-imaging P-value
N 1142 2476 10 107
Age, years 61.9+11.1 62.6+11.2 63.7+12.8 ,0.001
Male 853 (74.7) 1852 (74.8) 6992 (69.2) ,0.001
Risk factors
Hypertension 589 (53.9) 1465 (62.0) 5037 (54.6) ,0.001
Diabetes 206 (18.1) 500 (20.5) 1981 (20.3) 0.210
Dyslipidaemia 600 (55.3) 1413 (60.4) 4347 (48.0) ,0.001
Current smokers 299 (26.3) 576 (23.5) 2345 (24.1) 0.180
Family history 471 (44.0) 1025 (44.2) 3248 (36.6) ,0.001
History
Prior myocardial infarction 344 (30.1) 776 (31.3) 2324 (23.4) ,0.001
Prior CABG 50 (4.4) 136 (5.5) 1002 (10.1) ,0.001
Prior PCI 529 (46.3) 1058 (42.7) 2682 (26.9) ,0.001
Renal Failure 60 (5.3) 224 (9.1) 1260 (12.7) ,0.001
Indications for catheterization ,0.001
Stable angina 433 (37.9) 1114 (45.0) 2768 (27.4) ,0.001
Unstable angina 180 (15.7) 466 (18.8) 1552 (15.4) ,0.001
Non-STEMI 97 (8.5) 233 (9.4) 1271 (12.6) ,0.001
STEMI 282 (24.7) 360 (14.5) 2787 (27.6) ,0.001
Other 150 (13.1) 303 (12.2) 1729 (17.1) ,0.001
Lesion type, n 946 1927 7263 ,0.001
A 115 (12.2) 214 (11.1) 571 (7.9) ,0.001
B1 235 (24.8) 519 (26.9) 1690 (23.3) 0.003
B2 358 (37.8) 729 (37.8) 2398 (33.0) ,0.001
C 238 (25.2) 465 (24.1) 2604 (35.9) ,0.001
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contrast exposure has to be kept to a minimum. This explains the
smaller numbers of patients with renal impairment in the OCT
and, in lesser extent, the IVUS group. In patients with a chronic total
occlusion (lesion type C), operators are less inclined to use invasive
imaging, while additional imaging can be of great help in complex le-
sions (type B2), such as bifurcations. We believe that our data reflect
the diversity in the use of invasive imaging and its many possible
applications.
Figure 1 Examples of the use of OCT in different clinical settings. Angiogram (A) of a STEMI patient with corresponding OCT cross-sectional
images (B and C) with the presence of thrombus (+). Angiogram (D) of a severely calcified vessel, which is clearly appreciated (CA) on the OCT
images (E and F ) after lesion preparation with a cutting balloon and rotablator. Angiogram (G) of a patient with in-stent restenosis. The OCT
images reveal a lesion with neoatherosclerosis within the stent (H and I ). Angiographic (J ) and OCT image acquisition (K and L) in a recanalized
chronic total occlusion. *Guide wire artefact.
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Previous studies demonstrating the
safety of OCT
OCT’s need of clearance of blood from the vessel during image
acquisition was perceived as the Achilles heel in the early days of
intracoronary OCT imaging with time-domain technology, limiting
its clinical application to a few expert centres. Today, this problem
is largely solved by the introduction of FD-OCT technology. With
FD-OCT, the need to clear the artery temporarily from blood
does not appear as a major drawback anymore. The first studies
that reported the safety of OCT10,11 used the currently abandoned
TD-OCT systems. At that time, OCT image acquisition was relative-
ly slow (frame rate 15 frames/s and pullback speed of 1 mm/s) and
thus requiring longer pullback times with temporary occlusion of
the proximal vessel segment using a dedicated occlusion balloon.
Prati et al. 5 were the first to perform OCT with a pullback speed
of 3 mm/s and a non-occlusive technique demonstrating improved
feasibility and reduced complication risk. This was then confirmed
in a larger multicentre registry6 comparing the occlusive balloon
technique (n ¼ 256) to the non-occlusive TD-OCT (n ¼ 212)
technique. No major adverse cardiac events (MACE) were
observed during or in the 24 h period following OCT imaging.
The first study to report the safety and feasibility of FD-OCT was
published by Imola et al. 7 in a group of 90 patients with unstable or
stable coronary artery disease. In this population, one case of cor-
onary spasm was recorded, but no MACE were observed. Likewise,
two other studies8,9 reported FD-OCT safety in small, selected
groups. Our study presents safety of OCT in a high-volume centre,
over several years. The findings corroborate the results of the prior,
smaller studies with complication rates of 0–2%. The few complica-
tions that were encountered were all resolved before the patient
left the catheterization laboratory. These complications were also
in line with individual case reports that described rare adverse
events during OCT imaging.12– 15 Importantly, our large-scale, sys-
tematic registry can demonstrate that these complications occur
very rarely (all ,0.2%) in a tertiary, high-volume centre and seem
to happen randomly.
Comparison with IVUS
Although IVUS image acquisition shows many similarities to that of
OCT, there are some distinct differences, most importantly IVUS’s
lack of need for a temporarily blood-free environment. Despite the
differences, complications are seen very rarely for both modalities
and do not significantly differ. In our study, we report 12 (0.5%)
adverse events during IVUS image acquisition.
Large IVUS safety trials have been performed,16,17 reporting 1–
3% complications, a number that may be partially driven by a larger
catheter size. The most recent large-scale study implementing IVUS,
the PROSPECT18 study, reported 11 patients (1.6%) with complica-
tions that were attributed to IVUS procedures. In contrast to our
findings, all events were caused by mechanical damage (10 dissec-
tions and 1 perforation) to the vessel wall. The reasons for this dif-
ference is unclear. The mean number of vessels that were imaged
with IVUS in our cohort is 1.28 per procedure, in contrast to the
three vessels that were imaged as part of the protocol in the PRO-
SPECT study. Furthermore, in the PROSPECT study, images were
acquired within a shorter time window and in multiple centres.
Risk factors for adverse event
We did not find any patient characteristics, nor any procedural-
related characteristics that increase the chance of occurrence of
an imaging-related event in the light of our very low event rate.
The absence of risk factors most likely demonstrates that adverse
events occur infrequently and randomly, implicating that OCT and
IVUS can both be used in a large variety of patients and in different
clinical settings. We additionally explored if the amount of adverse
events declined with increasing experience; however, an association
between the operator’s experience and the number of imaging
procedures was not identified, tracking with previous reports.9
Limitations
A limitation of this study is its design. Collection of data has been
recorded over several years as part of our clinical routine catheter-
ization database. This could possibly cause inconsistency and create
bias. Furthermore, reproduction of the procedures associated
with adverse events that occurred during coronary catheterizations
that were performed years ago can be complex. However, the
Figure 2 Event rates of IVUS and OCT after adjudication.
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Table 4 Invasive imaging complications after
adjudication
OCT IVUS P-value
Transient ST-elevation 3 (0.26) 2 (0.08) 0.2
Bradycardia 2 (0.18) 1 (0.04) 0.2
Coronary spasm 1 (0.09) 1 (0.04) 0.6
Thrombus formation 1 (0.09) 4 (0.16) 0.6
Dissection 0 (0.00) 3 (0.12) 0.2
Stent deformation 0 (0.00) 1 (0.04) 0.5
Major adverse events 0 (0.00) 0 (0.00) NA
Values in n (%).
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registration of events is done by experienced operators in a standar-
dized way and for a long period of time. We included every patient
undergoing FD-OCT and IVUS within the selected time window and
used all available procedural data to reproduce the procedures with
two independent adjudication committees. Therefore, we feel that
the reported results represent clinical practice. The fact that imaging
was acquired at the discretion of very experienced operators could
create selection bias. Moreover, the high level of experience in this
single-centre study does not mean that reported results can be
translated to less experienced centres. Furthermore, it is of note
that it is possible that the differences in clinical characteristics be-
tween OCT, IVUS, and non-imaging groups as presented in Table 3
were mainly driven by its use in predefined research protocols in
specific clinical settings. However, we intentionally included all
imaging procedures that have taken place within the specified
time window to assure that the presented data represent a modern,
real-world catheterization laboratory population. Success rates of
individual pullbacks were not routinely recorded in our databases.
Therefore, we were unable to report on the feasibility of
OCT image acquisition in daily clinical practice.
Another limitation of this study is that we were not able to report
the incidence of peri-procedural myocardial infarctions and
contrast-induced nephropathy, as the majority of our patients are
being transferred to the referring hospital within 6 h after the pro-
cedure or dismissed after an uneventful procedure.
Conclusion
FD-OCT is safe in an unselected and heterogeneous group of pa-
tients with varying clinical settings. Adverse events that occur during
image acquisition are rare, and similar to the event rates occurring
during IVUS image acquisition.
Supplementary data
Supplementary data are available at European Heart Journal – Cardio-
vascular Imaging online.
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